Lobe Sciences Ltd. (LOBEF)
USD 0.03
(16.28%)
USD 0.03
(16.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.71 Million | -2.73 Million | -5.03 Million | -1.22 Million | -2.04 Million | -51.93 Thousand |
| Net Income | -4.7 Million | -12.25 Million | -22.82 Million | -3.43 Million | -754.43 Thousand | -51.79 Thousand |
| Depreciation & Amortization | 43.69 Thousand | 10.22 Thousand | 6.54 Million | 561.48 Thousand | 210.41 Thousand | - |
| Deferred income taxes | 959.25 Thousand | 999.22 Thousand | -1.02 Million | 885.01 Thousand | -3.93 Million | - |
| Stock-based compensation | 301.76 Thousand | 620.61 Thousand | 921.59 Thousand | 744.14 Thousand | 1.23 Million | - |
| Change in working capital | 1.51 Million | 847.52 Thousand | 185.18 Thousand | -18.99 Thousand | -322.77 Thousand | -139.00 |
| Other non-cash items | 167.64 Thousand | 7.04 Million | 11.15 Million | 42.01 Thousand | 1.52 Million | - |
| Investing Cash Flow | - | 1.74 Million | 1.06 Million | 198.74 Thousand | -463.75 Thousand | - |
| Investments in PPE | - | - | - | - | -265.1 Thousand | - |
| Acquisitions | - | - | -137.02 Thousand | 198.74 Thousand | -198.65 Thousand | - |
| Investment purchases | - | - | -445.4 Thousand | - | - | - |
| Sales/Maturities of investments | - | 1.74 Million | - | - | - | - |
| Other Investing Activities | - | 1.74 Million | 1.64 Million | 198.74 Thousand | -199.76 Thousand | - |
| Financing Cash Flow | 950.01 Thousand | 753.11 Thousand | 4.91 Million | 718.73 Thousand | 474.74 Thousand | - |
| Debt repayment | -337.01 Thousand | - | -87.81 Thousand | -162.64 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 613 Thousand | 753.11 Thousand | 5.17 Million | 585 Thousand | 1.07 Million | - |
| Other Financing Activities | -102.49 Thousand | 753.11 Thousand | -168.33 Thousand | 296.37 Thousand | -599.55 Thousand | - |
| Accounts receivables | 3367.00 | 177.42 Thousand | -143.19 Thousand | 107.63 Thousand | -324.51 Thousand | - |
| Accounts payables | 1.32 Million | 497.3 Thousand | 241.57 Thousand | 204.47 Thousand | 381.57 Thousand | 220.00 |
| Inventory | 23.94 Thousand | - | - | -107.63 Thousand | 324.51 Thousand | - |
| Other working capital | 167.93 Thousand | 172.8 Thousand | 86.79 Thousand | -223.47 Thousand | -704.34 Thousand | -359.00 |
| Cash at beginning of period | 907.53 Thousand | 1.14 Million | 172.1 Thousand | 512.77 Thousand | 2.48 Million | 34.52 Thousand |
| Cash at end of period | 140.29 Thousand | 907.53 Thousand | 1.14 Million | 172.1 Thousand | 512.77 Thousand | 29.52 Thousand |
| Capital Expenditure | - | - | - | - | -265.1 Thousand | - |
| Effect of forex changes on cash | 1384.00 | - | 22.68 Thousand | -35.72 Thousand | 58.73 Thousand | - |
| Net cash flow / Change in cash | -767.24 Thousand | -234.3 Thousand | 969.73 Thousand | -340.67 Thousand | -1.97 Million | -4995.00 |
| Free Cash Flow | -1.71 Million | -2.73 Million | -5.03 Million | -1.22 Million | -2.3 Million | -51.93 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -426.8 Thousand | -595.47 Thousand | -568.02 Thousand | -1.37 Million | -4.7 Million | -312.1 Thousand |
| Depreciation & Amortization | 28.23 Thousand | 28.23 Thousand | 28.23 Thousand | 24.59 Thousand | 43.69 Thousand | 17.33 Thousand |
| Deferred income taxes | - | - | 299.32 Thousand | 1.03 Million | 959.25 Thousand | -422.63 Thousand |
| Stock-based compensation | 58.73 Thousand | 58.32 Thousand | 45.7 Thousand | 128.75 Thousand | 301.76 Thousand | 76.84 Thousand |
| Change in working capital | 206.09 Thousand | 471.59 Thousand | 375.71 Thousand | 534.1 Thousand | 1.51 Million | 719.33 Thousand |
| Other non-cash items | -135.76 Thousand | -332.61 Thousand | -275.73 Thousand | -973.01 Thousand | 167.64 Thousand | 447.58 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 337.8 Thousand | - | - | 11.21 Thousand | 950.01 Thousand | 55.77 Thousand |
| Debt repayment | -337.8 Thousand | - | - | - | -337.01 Thousand | -66.98 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -11.21 Thousand |
| Common Stock Issuance | - | - | - | 11.21 Thousand | 613 Thousand | -11.21 Thousand |
| Other Financing Activities | 337.8 Thousand | - | - | 11.21 Thousand | -102.49 Thousand | 66.98 Thousand |
| Accounts receivables | 974.00 | -6904.00 | 11.83 Thousand | -2860.00 | 3367.00 | 24.98 Thousand |
| Accounts payables | 61.76 Thousand | 460.36 Thousand | 387.9 Thousand | 1.21 Million | 1.32 Million | -336.09 Thousand |
| Inventory | - | 879.00 | 1757.00 | 23.94 Thousand | 23.94 Thousand | - |
| Other working capital | 143.35 Thousand | 18.13 Thousand | -25.77 Thousand | -908.79 Thousand | 167.93 Thousand | 1.03 Million |
| Cash at beginning of period | 5070.00 | 46.56 Thousand | 140.29 Thousand | 754.89 Thousand | 907.53 Thousand | 172.56 Thousand |
| Cash at end of period | 29.53 Thousand | 5070.00 | 46.56 Thousand | 140.29 Thousand | 140.29 Thousand | 754.89 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 8648.00 | -10.22 Thousand | 1061.00 | -440.00 | 1384.00 | 187.00 |
| Net cash flow / Change in cash | 24.46 Thousand | -41.49 Thousand | -93.72 Thousand | -614.6 Thousand | -767.24 Thousand | 582.33 Thousand |
| Free Cash Flow | -321.98 Thousand | -31.26 Thousand | -94.78 Thousand | -625.38 Thousand | -1.71 Million | 526.37 Thousand |
1708
PGPKY
VATN
NIPOF
CBVTF
MDG1